Nanoparticle-derived non-viral genetic transfection at the blood-brain barrier to enable neuronal growth factor delivery by secretion from brain endothelium

Current Medicinal Chemistry

Volumn 18, Issue 22, 2011, Pages 3330-3334

  Thomsen, L B ^a   Larsen, A B ^a   Lichota, J ^a   Moos, T ^a  

^a AALBORG UNIVERSITY   (Denmark)

Author keywords

Blood brain barrier; Drug delivery; Lipoplexes; Magnetic nanoparticles; Nanoparticle; Polyplexes; Pullulan; Transferrin receptor

Indexed keywords

ALBUMIN; APOLIPOPROTEIN E; COMPLEMENTARY DNA; DNA; DOXORUBICIN; DRUG CARRIER; FERRIC OXIDE; GROWTH FACTOR; HUMAN GROWTH HORMONE; IMMUNOLIPOSOME; LIPOPLEX; LIPOSOME; MACROGOL; MAGNETIC NANOPARTICLE; MAGNETITE NANOPARTICLE; MICRORNA; NANOPARTICLE; PLASMID DNA; POLYLACTIC ACID; POLYMER; POLYPLEX; POLYSORBATE 80; PULLULAN; SMALL INTERFERING RNA; SPERMINE; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; BRAIN CAPILLARY; BRAIN ENDOTHELIUM; CAPILLARY ENDOTHELIUM; CONFERENCE PAPER; CONTROLLED DRUG RELEASE; DRUG DESIGN; DRUG FORMULATION; DRUG TRANSPORT; ENDOTHELIUM; ENDOTHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HYDROPHILICITY; LIPOPHILICITY; MAGNETIC FIELD; MOLECULARLY TARGETED THERAPY; NANOENCAPSULATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PROTEIN SECRETION;

BLOOD-BRAIN BARRIER; BRAIN; DRUG CARRIERS; ENDOTHELIUM; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NANOPARTICLES; TRANSFECTION;

EID: 79961052298     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711796504637     Document Type: Conference Paper

References (39)

1. Pardridge, W.M. Brain drug targeting. Cambridge University Press, UK, 2001.
2. Lichota, J.; Skjoørringe, T.; Thomsen, L.B.; Moos, T. Macromolecular drug transport into brain using targeted therapy. J. Neurochem, 2010, 113, 1-13.
3. Davis, M.E; Pun, S.H.; Bellocq, N.C.; Reineke, T.M.; Popielarski, S.R.; Mishra, S.; Heidel, J.D. Self-assembling nucleic acid delivery vehicles via linear, water-soluble, cyclodextrin-containing polymers, Curr. Med. Chem., 2004, 11, 179-97. (Pubitemid 38128844)
4. Gregoriadis, G.; Wills, E.J.; Swain, C.P.; Tavill, A.S. Drug-carrier potential of liposomes in cancer chemotherapy, Lancet, 1974, 1, 1313-6.
5. Thomsen, L.B.; Lichota, J.; Kim, K.S.; Moos, T. Gene delivery by pullulan derivatives in brain capillary endothelial cells for protein secretion, J. Control. Release, 2011, 151, 45-50
6. Saiyed, Z.M.; Gandhi, N.H.; Nair, M.P.N. Magnetic nanoformulation of azidothymidine 5'-triphosphate for targeted delivery across the blood-brain barrier, Int J Nanomedicine, 2010, 5, 157-66.
7. Thomsen, L.B.; Lichota, J.; Larsen T.E.; Linemann, T.; Mortensen, J.H. Nielsen, K.G.D.J.; Moos, T. Brain delivery systems via mechanisms independent of receptor-mediated endocytosis and adsorptive mediated endocytosis, Curr Pharm Biotechnol., 2011, In print
8. Abbott, N.J.; Patabendige, A.A.; Dolman, D.E.; Yusof, S.R.; Begley, D.J. Structure and function of the blood-brain barrier. Neurobiol. Dis. 2010, 37, 13-25.
9. Persidsky, Y.; Ranirez, S.H.; Haorah, J.; Kanmogne, G.D. Blood-brain barrier: structral components and function under physiologic and pathologic conditions. J. Neuroimmune Pharmacol., 2006, 1, 223-36. (Pubitemid 44244128)
10. Witt, K.A.; Gillespie, T.J.; Huber, J.D.; Egleton, R.D.; Davis, T.P. Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability, Peptides, 2001, 22, 2329-43.
11. Jefferies, W.A.; Brandon, M.R.; Hunt, S.V.; Williams, A.F.; Gatter, K.C.; Mason, D.Y. Transferrin receptor on endothelium of brain capillaries. Nature, 1984, 312, 162-63. (Pubitemid 14000081)
12. Alam, M.L.; Beg, S.; Samad, A.; Baboota, S.; Kohli, K.; Ali, J.; Ahuja, A.; Akbar, M. Strategy for effective brain drug delivery, Eur J Pharm Sci, 2010, 40, 385-03.
13. Yoshikawa, B.U.; Pardridge, W.M. Delivery of peptides and proteins through the blood-brain barrier, Adv Drug Deliv Rev., 2001, 46, 247-79.
14. Joølck, R.I.; Feldborg, L.N.; Andersen, S.; Moghimi, S.M.; Andresen, T.L. Engineering liposomes and nanoparticles for biological targeting, Adv Biochem Engin Biotechnol, 2010, epub ahead of print.
15. Gosk, S.; Vermehren, C.; Storm, G.; Moos, T. Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion. J. Cereb. Blood Flow Metab.,2004, 24, 1193-1204. (Pubitemid 39482480)
16. Markoutsa, E.; Pampalakis, G.; Niarakis, A.; Romero, I.A.; Weksler, B.; Couraud, P.O.; Antimisiaris, S.G. Uptake and permeability studies of BBBtargeting immunoliposomes using the hCMEC/D3 cell line, Eur J. Pharm. Biopharm. 2010, Epub ahead of print.
17. Ying, X.; Wen, H.; Lu, W.L.; Du, J.; Guo, J.; Tian, W.; Men, Y.; Zhang, Y.; Li, R.J.; Yang, T.Y.; Shang, D.W.; Lou, J.N.; Zhang, L.R.; Zhang, Q. Dualtargeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals, J. Control. Release, 2010, 141, 183-92.
18. Safavy, A.; Raisch, K.P.; Matusiak, D.; Bhatnagar, S.; Helson, L. Singledrug multiligand conjugates: synthesis and preliminary cytotoxicity evaluation of a paclitaxel-dipeptide "scorpion" molecule, Bioconjugate Chem., 2006, 17, 565-70. (Pubitemid 43794364)
19. Andresen, T.L.; Jensen, S.S.; Joørgensen, K.; Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumour specific drug release, Prog. Lipid Res., 2005, 44, 68-97. (Pubitemid 40313220)
20. Strukel, J.M.; Li, R.C.; Maynard, H.D.; Caplan, M. Two-step synthesis of multivalent cancer-targeting constructs, Biomacromolecules, 2010, 11, 160-67.
21. Zhang, Y.; Zhu, C.; Pardridge, W.M. Antisense gene therapy of brain cancer with an artificial virus gene delivery system, Mol. Ther., 2002, 6, 67-72. (Pubitemid 36124272)
22. Tan, P.H.; Manunta, M.; Ardjomand, N.; Xue, S.A.; Larkin, D.F.; Haskard, D.O.; Taylor, K.M.; George, A.J. Antibody targeted gene transfer to endothelium, J. Gene Med., 2003, 5, 311-23. (Pubitemid 40310383)
23. Shi, N.; Zhang, Y.; Zhu, C. Brain-specific expression of an exogenous gene after i.v. administration. Proc. Natl Ascad Sci USA, 2001, 98, 12754-59.
24. Shu, C.; Zhang, Y.; Zhang, Y.F.; Yi, L.J.; Boado, R.J.; Pardridge, W.M. Organ-Specific expression of the LacZ gene controlled by the opsin promoter after intravenous gene administration in adult mice. J Gene Med., 2004, 6, 906-12. (Pubitemid 40228106)
25. Zhao, H.; Li, G.L.; Wang, R.Z.; Li, S.F.; Wei, J.J.; Feng, M.; Zhao, Y.J.; Ma, W. B.; Yang, Y.; Li, Y.N.; Kong, Y.G. A comparative study of transfection efficiency between liposomes, immunoliposomes and brain-specific immunoliposomes, J. Int. Med. Res., 2010, 38, 957-66.
26. Elouahabi, A.; Ruysschaert, J.M. Formation and intracellular trafficking of liposomes and polyplexes, Mol. Ther, 2005, 11, 336-47. (Pubitemid 40277310)
27. Tarahovsky, Y.S. Cell transfection by DNA-lipid complexes - lipoplexes, Biochemistry (Mosc.), 2009, 74, 1293-04.
28. Tiwari, S.B.; Amiji, M.M. A review of nanoc rrier-based CNS delivery systems, Cur. Drug. Deliv., 2006, 3, 219-32. (Pubitemid 43738987)
29. Teixido, M.; Giralt, E. The role of peptides in blood-brain barrier nanotechnology, J. Pept. Sci., 2008, 14, 163-73. (Pubitemid 351284912)
30. Zhang, H.; Vinogradov, S.V. Short degradeble polyamines for gene delivery and trasnfection of brain capillary endothelial cells, J. Control. Release, 2010, 143, 359-66.
31. Kim, J.B.; Choi, J.S.; Nam, K.; Lee, M.; Park, J.S.; Lee, J.K. Enhanced transfection of primary cortical cultures using arginine-grafted PAMAM dendrimer, PAMAM-Arg. J Control Release, 2006, 114, 110-17. (Pubitemid 44128622)
32. Moghimi, S. M.; Symonds, P; Murray, J.C.; Hunter, A.C.; Debska, G.; Szewczyk, A. A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol. Ther., 2005, 11, 990-95. (Pubitemid 40724119)
33. Ren, T.; Xu, N.; Cao, C.;Yuan, W.;Yu, X.; Chen, J.; Ren, J. Preparation and Therapeutic Efficacy of Polysorbate-80-Coated Amphotericin B/PLA-b-PEG Nanoparticles, J. Biomater Sci. Polym. Ed., 2009, 20, 1369-80.
34. Zensi, A.; Begley, D.; Pontikis, C.; Legros, C.; Mihoreanu, L.; Wagner, S.; Büchel, C.; von Briesen, H.; Kreuter, J. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones, J. Control Release, 2009, 137, 78-86.
35. Jo, J.; Ikai, T.; Okazaki, A.; Yamamoto, M.; Hirano, Y.; Tabata, Y. Expression profile of plasmid DNA by spermine derivatives of pullulan with different extents of spermine introduced, J. Control. Release, 2007, 118, 389-98. (Pubitemid 46442881)
36. Jo, J.; Ikai, T.; Okazaki, A.; Nagane, K.; Yamamoto, M.; Hirano, Y.; Tabata, Y. Expression profile of plasmid DNA obtained using spermine derivatives of pullulan with different molecular weights, J. Biomater. Sci. Polym Ed, 2007, 18, 883-99. (Pubitemid 47184917)
37. Chertok, B.; Moffat, B.A.; David, A.E.; Yu, F.; Bregemann, C.; Ross, B.D.; Yang, V.C. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumours, Biomaterials, 2008, 29, 487-96. (Pubitemid 350100794)
38. Ku, S.; Yan, F.; Wang, Y.; Sun, Y.; Yang, N.; Ye, L. The blood-brain barrier penetration and distribution of PEGylated fluorescein magnetic silica nanoparticles in rat brain, Biochem. Biophys. Res. Commun., 2010, 294, 871-6.
39. Bhaskar, S.; Tian, F.; Stoeger, T.; Kreyling, W.; de la Fuente, J.M.; Grazú, V.; Borm, P.; Estrada, G.; Ntziachristos, V.; Razansky, D. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging., Part Fibre Toxicol, 2010 7:3.